Health Canada open data (page 49)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Notice: Submission Filing Recommendations for Veterinary Drugs - Good Manufacturing Practices and Drug Establishment Licences
- Guidance on Veterinary Drug Joint Reviews
- Guidance Document: Master Files for Veterinary Products: Procedures and Administrative Requirements
- Guidance For Industry Management of Regulatory Submissions
- Guidance for Industry Preparation of Veterinary New Drug submissions
- Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs
- Guidance document on classification of veterinary drugs and livestock feeds
- Updated - Guidance Document: Preparation of Regulatory Activities in the "Non-eCTD Electronic-Only" Format
- Health Canada: Compilation of research abstracts 2019-2020
- Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)
- Guidance Document: Tamper-resistance Formulations of Opioid Drug Products
- Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document
- Post-Notice of Compliance (NOC) Changes: Framework Document
- Guidance Document: Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
- Guidance document: Post-Notice of Compliance (NOC) Changes: Framework Document (Pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
- Post-Notice of Compliance (NOC) Changes – Quality Guidance
- Guidance Document: Determining Prescription Status for Human and Veterinary Drugs
- Guidance for Industry - Priority Review of Drug Submissions
- Guidance document: Product Monograph (2020)
- Guidance Document - Periodic Benefit-Risk Evaluation Report (PBRER) International Conference on Harmonisation (ICH) Topic E2C(R2)
- Notice - Adoption of the International Conference on Harmonisation (ICH) Guidance on Periodic Benefit Risk Evaluation Report - ICH Topic E2C(R2), as of March 1, 2013
- Health Product Vigilance Framework
- Guidance Document for Industry - Review of Drug Brand Names
- Notice to Stakeholders: Updates to the Opioid Patient Information Handout
- Opioid Warning Sticker and Patient Information Handout, and Risk Management Plans
- Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document
- Guidance Document: Questions and Answers: Plain Language Labelling Regulations for Non-prescription Drugs
- Guidance Document: The Management of Drug Submissions and Applications
- Guidance Document Non-Clinical Laboratory Study Data Supporting Drug Product Applications and Submissions: Adherence to Good Laboratory Practice
- Non-prescription Drugs: Category IV Monographs
- Guidance Document: Labelling of Pharmaceutical Drugs for Human Use
- Labelling requirements for non-prescription drugs guidance document
- Non-prescription Drugs: Labelling Standards - Drug Product
- Guidance Document: Pre-market Evaluation of Hepatotoxicity in Health Products
- Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products
- Guidance Document: Drug Facts Table for Non-prescription Drugs
- Guidance Document - Human-Use Antiseptic Drugs
- Haemodialysis Solutions
- Guidance when Developing Therapeutic Regimens for the Eradication of Helicobacter pylori in GI diseases
- Good manufacturing practices guide for drug products (GUI-0001) - Summary
- Guidance Document on the Distribution of Drugs as Samples - Summary
- Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary
- Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)
- Guideline on Preparation of DIN Submissions
- Guidance document - Safety and effectiveness requirements for high-level disinfectants and sterilants for use on reusable semi-critical and critical medical devices (2018)
- Guidance document - Safety and Effectiveness Requirements for Contact Lens Disinfectants (2018)
- Guidance Document: Data Protection under C.08.004.1 of the Food and Drug Regulations
- COVID-19 mRNA vaccines
- COVID-19 viral vector-based vaccines